Related Experiment Video
Updated: May 24, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Membranous glomerulonephritis, psoriasis and etanercept. A chance or causal association?
Enrique A Florit1, Isabel Ubeda-Aranda, Pablo Delgado-Conde
1Hospital Clínico San Carlos, Madrid, Spain. kiqueflorit@hotmail.com
Abstract:
Psoriasis is a cutaneous disease with systemic involvement. Tissue damage is considered to be immune-mediated, and etanercept currently provides effective treatment. Kidney injury arising from this condition has not yet been fully explained in the literature. We present a case of membranous nephropathy with C1q deposits followed by development of psoriasis. In this article we will review the possible association between these conditions and the response to this biological molecule.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease I: Introduction
The JAK-STAT Signaling Pathway
Acute Kidney Injury II: Pathophysiology

